AXSM
Axsome Therapeutics Inc
203.10$
-1.2%
vs. previous close
Closing price · As of: Sep 22, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | +467.3% | +440.8% | +42.5% | +65.5% | |
| – | – | +478.3% | +107.8% | +15.0% | -23.7% | +108.2% | +1,387.0% | +349.8% | +401.4% | +27.8% | +42.6% | |
| – | – | – | – | – | – | – | – | – | +445.4% | +44.1% | +67.7% | |
| – | +58.4% | +212.8% | -5.9% | +17.7% | +128.3% | +30.9% | -17.3% | -0.2% | +69.0% | +91.0% | -2.0% | |
| – | +73.7% | +162.2% | +13.6% | +29.8% | +45.4% | +112.5% | +130.6% | +86.0% | +79.8% | +39.2% | +84.0% | |
| – | +62.1% | +199.5% | -1.4% | +20.9% | +104.3% | +47.7% | +25.8% | +80.1% | +112.1% | +32.9% | +20.1% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -59.0% | -85.5% | +912.1% | -15.9% | +10.0% | +107.0% | +122.0% | +28.8% | -12.0% | +1.8% | -0.2% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -56.9% | +121.4% | +131.8% | -55.4% | +85.5% | +82.5% | +134.2% | -91.0% | -91.1% | -723.5% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.